IC261, a specific inhibitor of CK1δ/ε, promotes aerobic glycolysis through p53-dependent mechanisms in colon cancer

Liu, Min; Hu, Yuhan; Lu, Shuya; Lu, Manman; Li, Jingsong; Chang, Haimin; Jia, Huijie; Zhou, Min; Ren, Feng; Zhong, Jiateng

doi:10.7150/ijbs.40960



Theranostics

International Journal of Medical Sciences

Nanotheranostics

Journal of Cancer

Journal of Genomics

Global reach, higher impact

Full Text | PDF

Int J Biol Sci 2020; 16(5):882-892. doi:10.7150/ijbs.40960 This issue Cite

Research Paper

IC261, a specific inhibitor of CK1δ/ε, promotes aerobic glycolysis through p53-dependent mechanisms in colon cancer

Min Liu^1*, Yuhan Hu^1*, Shuya Lu¹, Manman Lu¹, Jingsong Li², Haimin Chang³, Huijie Jia¹, Min Zhou¹, Feng Ren^1✉, Jiateng Zhong^1,2✉

1. Department of Pathology, Xinxiang Medical University, Henan, China
2. Department of Pathology, The First Affiliated Hospital of Xinxiang Medical University, Henan, China
3. The Academic Affairs Office, Xinxiang Medical University, Henan, China
* contributed equally to this work.

Citation:

Liu M, Hu Y, Lu S, Lu M, Li J, Chang H, Jia H, Zhou M, Ren F, Zhong J. IC261, a specific inhibitor of CK1δ/ε, promotes aerobic glycolysis through p53-dependent mechanisms in colon cancer. Int J Biol Sci 2020; 16(5):882-892. doi:10.7150/ijbs.40960. https://www.ijbs.com/v16p0882.htm

Other styles

Abstract

Casein kinase 1δ (CK1δ) and casein kinase 1ε (CK1ε) have been proposed to be involved in DNA replication, differentiation and apoptosis, thus participating in the regulation of tumorigenesis. However, their functions in colon cancer and the underlying mechanism remain unclear. Here, we found that the expression of CK1ε and CK1δ increased significantly in cancer tissues and the upregulation of CK1ε and CK1δ were closely related to poor differentiation, advanced TNM stage and poor prognosis of colon cancer. CK1δ/ε inhibitor IC261 could induce a decrease in cell survival and proliferation, and an increase in apoptosis in colon cancer cells. Interestingly, IC261 increased the level of aerobic glycolysis in colon cancer cells. Meanwhile, IC261 caused the decrease of p53 protein level and the misregulation of glycolysis related genes (TIGAR, G6PD, GLUT1) which are closely related to the regulation of glycolysis by p53. Inhibiting p53 by siRNA or inhibitor could significantly attenuate the upregulation of aerobic glycolysis induced by IC261. Finally, inhibition of aerobic glycolysis can further increase the cytotoxicity induced by IC261. Collectively, our results revealed that IC261 could inhibit the growth of colon cancer cells and increase the level of aerobic glycolysis, which is regulated by p53-dependent manner. This result suggested that targeting CK1δ/ε and glycolysis might be a valuable strategy treatment and combination therapies for colon cancer.

Keywords: colon cancer, casein kinase, aerobic glycolysis, IC261

Citation styles

APA

Liu, M., Hu, Y., Lu, S., Lu, M., Li, J., Chang, H., Jia, H., Zhou, M., Ren, F., Zhong, J. (2020). IC261, a specific inhibitor of CK1δ/ε, promotes aerobic glycolysis through p53-dependent mechanisms in colon cancer. International Journal of Biological Sciences, 16(5), 882-892. https://doi.org/10.7150/ijbs.40960.

ACS

Liu, M.; Hu, Y.; Lu, S.; Lu, M.; Li, J.; Chang, H.; Jia, H.; Zhou, M.; Ren, F.; Zhong, J. IC261, a specific inhibitor of CK1δ/ε, promotes aerobic glycolysis through p53-dependent mechanisms in colon cancer. Int. J. Biol. Sci. 2020, 16 (5), 882-892. DOI: 10.7150/ijbs.40960.

NLM

CSE

Liu M, Hu Y, Lu S, Lu M, Li J, Chang H, Jia H, Zhou M, Ren F, Zhong J. 2020. IC261, a specific inhibitor of CK1δ/ε, promotes aerobic glycolysis through p53-dependent mechanisms in colon cancer. Int J Biol Sci. 16(5):882-892.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.